Peter Attia· MD
what it really comes down to is you know we want to know what an individual's carbohydrate tolerance is okay i mean that's key to personalization right does everybody need to be very low carbohydrate low carbohydrate i mean where does we can say population level what happens in large clinical trials but what's happening with the individual